Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis

Author: Sterrenburg M.D.   Veltman-Verhulst S.M.   Eijkemans M.J.C.   Hughes E.G.   Macklon N.S.   Broekmans F.J.   Fauser B.C.J.M.  

Publisher: Oxford University Press

ISSN: 1460-2369

Source: Human Reproduction Update, Vol.17, Iss.2, 2011-10, pp. : 184-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content